Johnson & Johnson Q4 earnings beat estimates amid strength in medtech

Johnson & Johnson JNJ, +0.49% said Tuesday it had net earnings of $4.132 billion, or $1.70 a share, for the fourth quarter, up from $3.227 billion, or $1.22 a share, in the year-earlier period. Adjusted per-share earnings came to $2.29, just ahead of the $2.28 FactSet consensus. Sales rose to $21.395 billion from $19.939 billion a year ago, also ahead of the $21.022 billion FactSet consensus. By segment, sales at the company’s innovative medicine business, including COVID vaccines, rose 4.8% to $13.722 bil ...